US Patent Issued to THE REGENTS OF THE UNIVERSITY OF MICHIGAN on Aug. 4 for "Detection of colonic neoplasia in vivo using near-infrared peptide targeted against overexpressed cMet" (Michigan Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,402, issued on Aug. 4, was assigned to THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Mich.).

"Detection of colonic neoplasia in vivo using near-infrared peptide targeted against overexpressed cMet" was invented by Thomas D. Wang (Ann Arbor, Mich.) and Juan Zhou (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides peptides, including labeled peptides, that selectively bind to the cMet protein. The disclosure also provides methods of detecting dysplastic cells and tissue, e.g., in the colon, providing early identification of precancerous and cancerous tissue."

The patent was filed on Feb. 21, 2020, under App...